Neogenomics Inc Sample Contracts

AutoNDA by SimpleDocs
RECITALS
Consulting Agreement • November 19th, 2001 • American Communications Enterprises Inc • Radio & tv broadcasting & communications equipment • Florida
ESCROW AGREEMENT
Escrow Agreement • June 8th, 2005 • Neogenomics Inc • Services-commercial physical & biological research • New Jersey
LETTER OF INTENT BY AND BETWEEN AMERICAN COMMUNICATIONS ENTERPRISES, INC. And AEROGROUP INCORPORATED
American Communications Enterprises Inc • August 20th, 2001 • Radio & tv broadcasting & communications equipment • Florida
NeoGenomics, Inc. (a Nevada corporation)
Underwriting Agreement • January 11th, 2021 • Neogenomics Inc • Services-testing laboratories • New York

NeoGenomics, Inc., a Nevada corporation (the “Company”), confirms its agreement with BofA Securities, Inc. (“BofA Securities”), Morgan Stanley & Co. LLC (“Morgan Stanley”) and Goldman Sachs & Co. LLC (“Goldman Sachs”), as representatives (the “Representatives”) of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective principal amounts set forth on Schedule A hereto of $300,000,000 aggregate principal amount of the Company’s 0.25% Convertible Senior Notes due 2028 (“Initial Securities”) and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase, solely to cover over-allotments, all or any part of an additional $45,000,000 aggregate pr

BACKGROUND
Registration Rights Agreement • March 30th, 2005 • Neogenomics Inc • Services-commercial physical & biological research • Nevada
RECITALS --------
Loan and Security Agreement • May 20th, 2003 • Neogenomics Inc • Services-commercial physical & biological research • Florida
RECITALS --------
Loan and Security Agreement • May 20th, 2003 • Neogenomics Inc • Services-commercial physical & biological research • Florida
NEOGENOMICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of January 11, 2021 0.25% Convertible Senior Notes due 2028
Indenture • January 11th, 2021 • Neogenomics Inc • Services-testing laboratories • New York

INDENTURE, dated as of January 11, 2021, between NEOGENOMICS, INC., a Nevada corporation, as issuer (the “Company”, as more fully set forth in Section 1.01) and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).

RECITALS
Loan Agreement • March 30th, 2005 • Neogenomics Inc • Services-commercial physical & biological research • Florida
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • November 7th, 2008 • Neogenomics Inc • Services-testing laboratories • Nevada

REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of November 5, 2008, by and between NEOGENOMICS, INC., a Nevada corporation, (the "Company"), and FUSION CAPITAL FUND II, LLC (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 15th, 2007 • Neogenomics Inc • Services-testing laboratories • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 17, 2007, between Power3 Medical Products, Inc., a New York corporation (the “Company”), and NeoGenomics, Inc. a Nevada Corporation, (the “Purchaser”).

RECITALS:
Employee Stock Option Agreement • November 19th, 2001 • American Communications Enterprises Inc • Radio & tv broadcasting & communications equipment • Florida
AutoNDA by SimpleDocs
—] Shares1 NeoGenomics, Inc. Common Stock, par value $0.001 per share PURCHASE AGREEMENT
Purchase Agreement • February 28th, 2013 • Neogenomics Inc • Services-testing laboratories • New York

NeoGenomics, Inc., a Nevada corporation (the “Company”), and the stockholder of the Company listed in Schedule I hereto (the “Selling Stockholder”) severally propose to sell to the several underwriters named in Schedule II hereto (the “Underwriters”) an aggregate of [—] shares (the “Firm Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company. The Firm Shares consist of [—] authorized but unissued shares of Common Stock to be issued and sold by the Company and [—] outstanding shares of Common Stock to be sold by the Selling Stockholder. The Company also has granted to the several Underwriters an option to purchase up to [—] additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”

CREDIT AGREEMENT by and among WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, THE LENDERS THAT ARE PARTIES HERETO as the Lenders, NEOGENOMICS, INC., as Parent, NEOGENOMICS LABORATORIES, INC., PATH LABS, LLC, and the other parties...
Credit Agreement • December 31st, 2015 • Neogenomics Inc • Services-testing laboratories • New York

THIS CREDIT AGREEMENT (this “Agreement”), is entered into as of December 30, 2015, by and among the lenders identified on the signature pages hereof (each of such lenders, together with its successors and permitted assigns, is referred to hereinafter as a “Lender”, as that term is hereinafter further defined), WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as administrative agent for each member of the Lender Group and the Bank Product Providers (in such capacity, together with its successors and assigns in such capacity, “Agent”), NEOGENOMICS, INC., a Nevada corporation (“Parent”), NEOGENOMICS LABORATORIES, INC., a Florida corporation (“NeoGenomics”), PATH LABS, LLC, a Delaware limited liability company (“PathLogic”), and the other parties signatory hereto as “Borrowers” from time to time (such other parties, together with NeoGenomics and PathLogic, are referred to hereinafter each individually as a “Borrower”, and individually and collectively, jointly and se

INVESTOR REGISTRATION RIGHTS AGREEMENT
Investor Registration Rights Agreement • July 6th, 2007 • Neogenomics Inc • Services-testing laboratories • Nevada

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May ___, 2007, by and among NEOGENOMICS, INC., a Nevada corporation (the “Company”), and [NAME OF INVESTOR], a ___________ _____ (the “Investor”).

GUARANTY --------
Neogenomics Inc • May 20th, 2003 • Services-commercial physical & biological research • Florida
EXHIBIT 7
Time Brokerage Agreement • August 26th, 1999 • American Communications Enterprises Inc • Radio & tv broadcasting & communications equipment • Texas
RECITALS
Research and License Agreement • November 20th, 2002 • Neogenomics Inc • Services-commercial physical & biological research • California
UNDERWRITING AGREEMENT
Neogenomics Inc • August 10th, 2018 • Services-testing laboratories • New York
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • May 5th, 2021 • Neogenomics Inc • Services-testing laboratories • New York

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of May 4, 2021 by and among NeoGenomics, Inc., a Nevada corporation (the “Company”), and the “Investors” named in that certain Securities Purchase Agreement by and among the Company and the Investors, dated as of May 4, 2021 (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!